Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit

MT Newswires Live

01-13

Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.

The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.

The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2503373639"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503373639\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2503373639?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503373639","market":"sh","top_or_hot":-1,"title":"Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit","media":"MT Newswires Live","content":"<html><body><p> Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.</p><p>The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.</p><p>The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Bio-heart Delays Dispatch of Circular for Stake Sale in Unit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-01-13 17:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.</p><p>The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.</p><p>The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02185","symbol_name":"百心安-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2503373639","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503373639","pubTimestamp":1736760273,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shanghai Bio-heart Biological Technology  delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02185":"百心安-B","BK1100":"医疗保健设备"},"translate_title":"上海生物心脏推迟发出出售单位股权的通函","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02185":0.9},"content_text":"Shanghai Bio-heart Biological Technology (HKG:2185) delayed the dispatch of a circular regarding the disposal of a 45.3% stake in Zhejiang Bioheart Medical Equipment to Jan. 27, a Friday Hong Kong bourse filing said.The interventional cardiovascular device company needs additional time to finalize certain information to be included in the circular.The firm is selling the stake to Jiaxing Guojian Baixin Equity Investment Partnership Enterprise in exchange for a 155.6 million yuan capital injection in the unit, according to a Jan. 2 disclosure.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}